Kidney stone disease: risk factors, pathophysiology and managementMatteo Bargagli, Daniel G. Fuster, Martin Scoglio et al.|Nature Reviews Nephrology|2025Cited by 43
Indapamide or chlorthalidone to reduce urine supersaturation for secondary prevention of kidney stones: protocol for a randomised, double-blind, cross-over trial (INDAPACHLOR)Martin Scoglio, Daniel G. Fuster, Sven Trelle et al.|BMJ Open|2025Cited by 2
Indapamide and Chlorthalidone to Reduce Urine Supersaturation for Secondary Prevention of Kidney Stones: Randomized, Double-Blind, Crossover Trial (INDAPACHLOR Trial)Martin Scoglio, Daniel G. Fuster, Matteo Bargagli|Journal of the American Society of Nephrology|2025Cited by 0
Magnesium and kidney stones: a concise narrative reviewMartin Scoglio, Daniel G. Fuster, Matteo Bargagli|Clinical Kidney Journal|2026Cited by 0